SDI
Greg Hess, MD MBA has extensive work experience in the healthcare industry. Greg started their career at Novartis in 1992, where they served as the Head of US Outcomes Research & Scientific Communications until 1994. Following this, they joined SmithKline Beecham as the Worldwide Vice President of Market Economics from 1994 to 2000. Since 2002, Greg has been working at Surveillance Data Inc., where they hold the position of Vice President.
Greg Hess, MD MBA, has a diverse education history. Greg earned their MD degree in Medicine from Albany Medical College, where they studied from 1980 to 1984. Afterward, they pursued an MBA degree in Strategic Planning & Marketing from The Wharton School, from 1991 to 1993. Later on, they furthered their education by obtaining an MSc degree in Health Services Research from Erasmus University Rotterdam, which they completed from 1996 to 1998.
SDI
On October 31, 2011, IMS Health completed the purchase of SDI Health, a Pennsylvania-based healthcare market insights and analytics firm. The acquisition brings together both companies’ considerable patient, specialty and managed markets information assets and services capabilities to provide a full, 360-degree view of the entire patient experience. IMS is now positioned to deliver more innovative and comprehensive information services to a broader set of stakeholders, including pharma manufacturers, public and private payers, healthcare providers, pharmacies and healthcare institutions, and other key constituents. ABOUT IMS IMS Health is the leading provider of information, services and technology for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, sophisticated analytics, on-shore and off-shore commercial services, and software platforms to help clients better understand the performance and value of medicines. With a presence in 100+ countries and more than 55 years of industry experience, IMS serves leading decision makers in healthcare, including pharmaceutical manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community. Additional information is available at http://www.imshealth.com.